Satellos Bioscience Stock Forward View - Polynomial Regression
| MSCL Stock | 11.55 -1.95 -14.44% |
Momentum
Sell Extended
Oversold | Overbought |
EPS Estimate Next Quarter -0.04 | EPS Estimate Current Year -1.68 | Wall Street Target Price 14.64 |
The hype view outlines Satellos Bioscience's attention response alongside peer coverage.
The Polynomial Regression forecasted value of Satellos Bioscience on the next trading day is expected to be 11.65 with a mean absolute deviation of 0.77 and the sum of the absolute errors of 47.77.Satellos Bioscience after-hype prediction price | C$ 10.89 |
The sentiment summary complements forecasting and technical views with analyst estimates and earnings data.
Satellos |
Satellos Bioscience Additional Predictive Modules
Most predictive techniques to examine Satellos price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Satellos using various technical indicators. When you analyze Satellos charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Polynomial Regression Price Forecast For the 14th of March 2026
Given 90 days horizon, the Polynomial Regression forecasted value of Satellos Bioscience on the next trading day is expected to be 11.65 with a mean absolute deviation of 0.77 , mean absolute percentage error of 0.91 , and the sum of the absolute errors of 47.77 .Please note that although there have been many attempts to predict Satellos Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Satellos Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest Satellos Bioscience | Satellos Bioscience Price Prediction | Research Analysis |
Forecasted Value
This next-day forecast for Satellos Bioscience uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Satellos Bioscience stock data series using in forecasting. Note that when a statistical model is used to represent Satellos Bioscience stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 119.8489 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.7704 |
| MAPE | Mean absolute percentage error | 0.0564 |
| SAE | Sum of the absolute errors | 47.7676 |
Investors who believe in mean reversion view Satellos Bioscience's price extremes not as permanent states but as temporary dislocations that create opportunities for disciplined, contrarian capital allocation.
After-Hype Price Density Analysis
The shape of Satellos Bioscience's price distribution after major news events tends to be skewed, with larger potential moves to the downside than to the upside for established companies like Satellos Bioscience. This asymmetry is a key input for options pricing and risk management.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
By studying Satellos Bioscience's historical news reactions, we generate empirical estimates of the price boundaries that follow significant headlines. Satellos Bioscience's after-hype downside and upside margins for the prediction period are 5.28 and 16.50, respectively. These estimates are most reliable when Satellos Bioscience's news reaction patterns have been consistent over multiple events.
Current Value
The after-hype framework applied to Satellos Bioscience assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Satellos Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Satellos Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Satellos Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.79 | 5.61 | 0.66 | 0.02 | 8 Events | 1 Events | In 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
11.55 | 10.89 | 5.71 |
|
Hype Timeline
Satellos Bioscience is now traded for 11.55on Toronto Exchange of Canada. The company has historical hype elasticity of -0.66, and average elasticity to hype of competition of -0.02. Satellos is estimated to decline in value after the next headline, with the price expected to drop to 10.89. The average volatility of media hype impact on the company price is over 100%. The price decline on the next news is expected to be -5.71%, whereas the daily expected return is now at 0.79%. The volatility of related hype on Satellos Bioscience is about 19635.0%, with the expected price after the next announcement by competition of 11.53. The company had not issued any dividends in recent years. Satellos Bioscience completed a 1:12 stock split on 30th of January 2026. Assuming the 90-day trading horizon the next estimated press release will be in 8 days. Cross-verify projections for Satellos Bioscience using Historical Fundamental Analysis of Satellos Bioscience. The analysis adds historical context for the projection set.Related Hype Analysis
News about regulatory changes, technological disruptions, or macroeconomic shifts can affect Satellos Bioscience's entire competitive landscape simultaneously. Monitoring peer reactions to such events helps investors anticipate Satellos Bioscience's likely response.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RX | Biosyent | -0.13 | 5 per month | 1.67 | 0.17 | 5.47 | -2.40 | 18.87 | |
| CRDL | Cardiol Therapeutics Class | 0.13 | 4 per month | 2.87 | 0.03 | 6.11 | -4.76 | 17.54 | |
| QIPT | Quipt Home Medical | -0.03 | 5 per month | 0.00 | 0.19 | 2.56 | -0.62 | 30.99 | |
| SVA | Sernova Corp | -0.01 | 2 per month | 2.61 | 0.11 | 7.69 | -6.67 | 27.31 | |
| HBP | Helix BioPharma Corp | -0.17 | 7 per month | 0.00 | -0.01 | 5.41 | -8.19 | 25.81 | |
| MDNA | Medicenna Therapeutics Corp | 0.01 | 7 per month | 0.00 | -0.22 | 5.43 | -6.78 | 18.29 | |
| ZEN | ZEN Graphene Solutions | 0.00 | 0 per month | 0.00 | -0.02 | 8.86 | -8.00 | 31.63 |
Other Forecasting Options for Satellos Bioscience
Investors at all stages of experience who consider Satellos must develop an understanding of Satellos Bioscience's price dynamics. The noise embedded in Satellos Stock price charts can create misleading signals and skew investment decisions.Satellos Bioscience Related Equities
The following equities are related to Satellos Bioscience within the Biotechnology space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing Satellos Bioscience against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
Satellos Bioscience Market Strength Events
Market strength indicators applied to Satellos Bioscience stock give investors a structured view of the security's momentum relative to the overall market. Using these indicators, traders can refine their timing when entering or exiting positions in Satellos Bioscience.
Satellos Bioscience Risk Indicators
Evaluating Satellos Bioscience's risk indicators is an important step in accurately forecasting its price and assessing the suitability of an investment. Understanding the risk profile of Satellos Bioscience's allows investors to make more informed decisions about position sizing and risk.
| Mean Deviation | 4.07 | |||
| Semi Deviation | 5.27 | |||
| Standard Deviation | 5.51 | |||
| Variance | 30.41 | |||
| Downside Variance | 33.79 | |||
| Semi Variance | 27.78 | |||
| Expected Short fall | -4.64 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Satellos Bioscience
Coverage intensity for Satellos Bioscience matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
Satellos Bioscience Short Properties
Short sentiment tied to Satellos Bioscience matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 9.6 M | |
| Cash And Short Term Investments | 69.9 M |
More Resources for Satellos Stock Analysis
Other Information on Investing in Satellos Stock
Financial ratios for Satellos Bioscience provide valuation context across profits, cash flow, and enterprise value. They help compare Satellos across valuation measures in a consistent way.